Financials

  • Market Capitalization 220.48 M
  • Employee 92
  • Founded 2015
  • CEO N/A
  • Website www.kerostx.com
  • Headquarter Massachusetts, United States
  • FIGI BBG00H1HP9G9
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.32
Relación precio/flujo de caja
29.78

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3542
PRQR
ProQR Therapeutics N.V. - Ordinary Shares
2.11 USD-0.94%-7.05%+21.97%-5.80%222.31 M USD
3545
NERV
Minerva Neurosciences, Inc - Common Stock
4.64 USD+1.75%-7.75%+17.47%+97.45%221.55 M USD
3563
GLSI
Greenwich LifeSciences, Inc. - Common stock
14.69 USD-1.74%-22.85%+8.81%+26.64%215.62 M USD
3565
CRBP
Corbus Pharmaceuticals Holdings, Inc. - Common Stock
11.14 USD+2.11%-0.18%+23.64%-32.89%215.46 M USD

Noticias